Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
Cosmos Health reported record preliminary nine-month 2026 revenue of approximately $54.3 million, up 19% year-over-year, with a record Q3 of approximately $17.4 million. The company reaffirmed its full-year 2026 revenue outlook of more than $90 million, implying roughly 38% growth over 2025's $65.3 million, and expects Q4 to be its strongest quarter on record. All figures are preliminary and unaudited; full Q3 results will come in the Form 10-Q.
Key figures
- Revenue
- 54300000
- Guidance
- Full-year 2026 revenue to surpass $90 million (reaffirmed), representing ~38% growth over 2025
- Revenue Yoy
- 19%
- Q3 revenue
- 17400000
- Fy2024 revenue
- 54400000
- Fy2025 revenue
- 65300000
- Q3 revenue yoy
- +2%
- Pharmacy network
- more than 1,500 pharmacies
- Nine month 2024 revenue
- 40200000
- Nine month 2025 revenue
- 45600000
- Contract manufacturing pipeline units
- more than 32.7 million units
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.